Global Bupivacaine Liposome Injection Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global Bupivacaine Liposome Injection market size will reach 652.86 Million USD in 2025 and is projected to reach 1,215.08 Million USD by 2032, with a CAGR of 9.28% (2025-2032). Notably, the China Bupivacaine Liposome Injection market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Bupivacaine Liposome Injection is a long-acting local anesthetic formulation that encapsulates bupivacaine, a commonly used pain-relieving drug, in liposomes. These liposomes, which are small lipid-based vesicles, help to gradually release the bupivacaine over an extended period, providing prolonged pain relief compared to traditional bupivacaine injections. This formulation is particularly useful for managing post-surgical pain, as it offers extended anesthesia without the need for repeated doses. Bupivacaine Liposome Injection is typically used in procedures like orthopedic, abdominal, and cardiac surgeries, where prolonged pain management is required. Its controlled release mechanism improves patient comfort by reducing the need for additional analgesics and minimizing the risk of side effects associated with frequent dosing.
The major global manufacturers of Bupivacaine Liposome Injection include Pacira Pharmaceuticals, Jiangsu Hengrui Pharma, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Bupivacaine Liposome Injection. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Bupivacaine Liposome Injection market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Bupivacaine Liposome Injection market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Bupivacaine Liposome Injection industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Bupivacaine Liposome Injection Include:
Pacira Pharmaceuticals
Jiangsu Hengrui Pharma
Bupivacaine Liposome Injection Product Segment Include:
133mg per Vial
266mg per Vial
Bupivacaine Liposome Injection Product Application Include:
Hospital
Clinic
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Bupivacaine Liposome Injection Industry PESTEL Analysis
Chapter 3: Global Bupivacaine Liposome Injection Industry Porter's Five Forces Analysis
Chapter 4: Global Bupivacaine Liposome Injection Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Bupivacaine Liposome Injection Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Bupivacaine Liposome Injection Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Bupivacaine Liposome Injection Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Bupivacaine Liposome Injection market size will reach 652.86 Million USD in 2025 and is projected to reach 1,215.08 Million USD by 2032, with a CAGR of 9.28% (2025-2032). Notably, the China Bupivacaine Liposome Injection market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Bupivacaine Liposome Injection is a long-acting local anesthetic formulation that encapsulates bupivacaine, a commonly used pain-relieving drug, in liposomes. These liposomes, which are small lipid-based vesicles, help to gradually release the bupivacaine over an extended period, providing prolonged pain relief compared to traditional bupivacaine injections. This formulation is particularly useful for managing post-surgical pain, as it offers extended anesthesia without the need for repeated doses. Bupivacaine Liposome Injection is typically used in procedures like orthopedic, abdominal, and cardiac surgeries, where prolonged pain management is required. Its controlled release mechanism improves patient comfort by reducing the need for additional analgesics and minimizing the risk of side effects associated with frequent dosing.
The major global manufacturers of Bupivacaine Liposome Injection include Pacira Pharmaceuticals, Jiangsu Hengrui Pharma, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Bupivacaine Liposome Injection. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Bupivacaine Liposome Injection market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Bupivacaine Liposome Injection market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Bupivacaine Liposome Injection industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Bupivacaine Liposome Injection Include:
Pacira Pharmaceuticals
Jiangsu Hengrui Pharma
Bupivacaine Liposome Injection Product Segment Include:
133mg per Vial
266mg per Vial
Bupivacaine Liposome Injection Product Application Include:
Hospital
Clinic
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Bupivacaine Liposome Injection Industry PESTEL Analysis
Chapter 3: Global Bupivacaine Liposome Injection Industry Porter's Five Forces Analysis
Chapter 4: Global Bupivacaine Liposome Injection Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Bupivacaine Liposome Injection Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Bupivacaine Liposome Injection Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Bupivacaine Liposome Injection Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Bupivacaine Liposome Injection Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Bupivacaine Liposome Injection Product by Type
- 1.2.1 133mg per Vial
- 1.2.2 266mg per Vial
- 1.3 Bupivacaine Liposome Injection Product by Application
- 1.3.1 Hospital
- 1.3.2 Clinic
- 1.4 Global Bupivacaine Liposome Injection Market Revenue and Sales Analysis
- 1.4.1 Global Bupivacaine Liposome Injection Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Bupivacaine Liposome Injection Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Bupivacaine Liposome Injection Market Sales Price Trend Analysis (2020-2032)
- 1.5 Bupivacaine Liposome Injection Market Development Status and Trends
- 1.5.1 Bupivacaine Liposome Injection Industry Development Status Analysis
- 1.5.2 Bupivacaine Liposome Injection Industry Development Trends Analysis
- 2 Bupivacaine Liposome Injection Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Bupivacaine Liposome Injection Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Bupivacaine Liposome Injection Market Analysis by Country
- 4.1 Global Bupivacaine Liposome Injection Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Bupivacaine Liposome Injection Revenue and Market Share by Country (2020-2025)
- 4.1.2 Global Bupivacaine Liposome Injection Revenue and Market Share Forecast by Country (2026-2032)
- 4.2 Global Bupivacaine Liposome Injection Sales Analysis by Country: 2024 VS 2025 VS 2032
- 4.2.1 Global Bupivacaine Liposome Injection Sales and Market Share by Country (2020-2025)
- 4.2.2 Global Bupivacaine Liposome Injection Sales and Market Share Forecast by Country (2026-2032)
- 4.3 United States Bupivacaine Liposome Injection Market Sales, Revenue and Growth Rate (2020-2032)
- 4.4 Germany Bupivacaine Liposome Injection Market Sales, Revenue and Growth Rate (2020-2032)
- 4.5 Japan Bupivacaine Liposome Injection Market Sales, Revenue and Growth Rate (2020-2032)
- 4.6 China Bupivacaine Liposome Injection Market Sales, Revenue and Growth Rate (2020-2032)
- 4.7 France Bupivacaine Liposome Injection Market Sales, Revenue and Growth Rate (2020-2032)
- 4.8 U.K. Bupivacaine Liposome Injection Market Sales, Revenue and Growth Rate (2020-2032)
- 4.9 South Korea Bupivacaine Liposome Injection Market Sales, Revenue and Growth Rate (2020-2032)
- 4.10 Canada Bupivacaine Liposome Injection Market Sales, Revenue and Growth Rate (2020-2032)
- 4.11 Italy Bupivacaine Liposome Injection Market Sales, Revenue and Growth Rate (2020-2032)
- 4.12 Russia Bupivacaine Liposome Injection Market Sales, Revenue and Growth Rate (2020-2032)
- 4.13 Mexico Bupivacaine Liposome Injection Market Sales, Revenue and Growth Rate (2020-2032)
- 4.14 Brazil Bupivacaine Liposome Injection Market Sales, Revenue and Growth Rate (2020-2032)
- 4.15 India Bupivacaine Liposome Injection Market Sales, Revenue and Growth Rate (2020-2032)
- 4.16 Vietnam Bupivacaine Liposome Injection Market Sales, Revenue and Growth Rate (2020-2032)
- 4.17 Thailand Bupivacaine Liposome Injection Market Sales, Revenue and Growth Rate (2020-2032)
- 4.18 South Africa Bupivacaine Liposome Injection Market Sales, Revenue and Growth Rate (2020-2032)
- 5 Competition by Manufacturers
- 5.1 Global Bupivacaine Liposome Injection Market Sales, Revenue and Sales Price by Key Manufacturers (2021-2025)
- 5.1.1 Global Bupivacaine Liposome Injection Market Sales by Key Manufacturers (2021-2025)
- 5.1.2 Global Bupivacaine Liposome Injection Market Revenue by Key Manufacturers (2021-2025)
- 5.1.3 Global Bupivacaine Liposome Injection Average Sales Price by Manufacturers (2021-2025)
- 5.2 Bupivacaine Liposome Injection Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Bupivacaine Liposome Injection Competitive Landscape Analysis
- 5.2.2 Global Key Manufacturers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Bupivacaine Liposome Injection Market Analysis by Type
- 6.1 Global Bupivacaine Liposome Injection Market Revenue Analysis by Type
- 6.1.1 Global Bupivacaine Liposome Injection Market Size Analysis by Type: 2024 & 2025 & 2032
- 6.1.2 Global Bupivacaine Liposome Injection Revenue and Forecast Analysis by Type (2020-2032)
- 6.2 Global Bupivacaine Liposome Injection Market Sales and Forecast Analysis by Type (2020-2032)
- 6.3 Global Bupivacaine Liposome Injection Sales Price Trend Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Pacira Pharmaceuticals
- 7.1.1 Pacira Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Pacira Pharmaceuticals Bupivacaine Liposome Injection Product Portfolio
- 7.1.3 Pacira Pharmaceuticals Bupivacaine Liposome Injection Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.2 Jiangsu Hengrui Pharma
- 7.2.1 Jiangsu Hengrui Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Jiangsu Hengrui Pharma Bupivacaine Liposome Injection Product Portfolio
- 7.2.3 Jiangsu Hengrui Pharma Bupivacaine Liposome Injection Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Bupivacaine Liposome Injection Industry Chain Analysis
- 8.2 Bupivacaine Liposome Injection Industry Upstream Supply Analysis
- 8.2.1 Upstream Key Raw Material Supply Analysis
- 8.2.2 Raw Material Suppliers and Contact Information
- 8.3 Bupivacaine Liposome Injection Product Downstream Application Analysis
- 8.3.1 Global Bupivacaine Liposome Injection Revenue Market Size by Application: 2024 & 2025 & 2032
- 8.3.2 Global Bupivacaine Liposome Injection Revenue and Forecast Analysis by Application (2020-2032)
- 8.3.3 Global Bupivacaine Liposome Injection Sales and Forecast Analysis by Application (2020-2032)
- 8.4 Bupivacaine Liposome Injection Typical Downstream Customers
- 8.5 Bupivacaine Liposome Injection Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
